alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>




                                                                    EXHIBIT 32.2


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of uWink, Inc. (the "Company") on Form
10-QSB for the quarter ending June 30, 2005 as filed with the Securities and
Exchange Commission on the date hereof (the "Report"), I, Nolan k. Bushnell,
Chief Financial Officer and Chief Accounting Officer of the Company, hereby
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1)      The report fully complies with the requirements of Section 13(a) or
         15(d) of the Securities Exchange Act of 1934; and

(2)      The information contained in the Report fairly presents, in all
         material respects, the financial condition and results of operations of
         the Company.



August 15, 2005                                      By:   /s/ NOLAN K. BUSHNELL
                                                        ------------------------
                                                        Nolan K. Bushnell
                                                        Chief Financial Officer
                                                        Chief Accounting Officer
#### John Williard HILL, a/k/a Jay Hill, Petitioner-Appellant, v. Mr. CONROY; Attorney General for the State of Maryland, Respondents-Appellees.

No. 02-6852.

United States Court of Appeals, Fourth Circuit.

Submitted Aug. 15, 2002.

Decided Aug. 22, 2002.

John Williard Hill, Appellant Pro Se. John Joseph Curran, Jr., Attorney General, Mary Ann Rapp Ince, Office of the Attorney General of Maryland, Baltimore, Maryland, for Appellees.

Before NIEMEYER, LUTTIG, and WILLIAMS, Circuit Judges.

Dismissed by unpublished PER CURIAM opinion.

PER CURIAM.

John Williard Hill seeks to appeal the district court’s order denying relief on his petition filed under 28 U.S.C. § 2254 (2000). We have reviewed the record and the district court’s opinion and find no reversible error. Accordingly, we deny a certificate of appealability and dismiss the appeal on the reasoning of the district court. *See Hill v. Conroy,*No. CA-01-3576 (D.Md. May 21, 2002). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

*DISMISSED.*
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 97-6006

WILBUR DAVIS,

Plaintiff - Appellant,

versus

JAN BAXLEY; LEAH DEVLIN, Director, Health Services; VERNON MALONE, Chairman; J. STEWART

ADCOCK, Vice Chairman; BETTY LOU WARD, Commissioner; JOHN H. BAKER, Sheriff; SHELIA FORTE

RAY, Director of Jail; RICHARD Y. STEVENS,

Clerk to the Board,

Defendants - Appellees.

Appeal from the United States District Court for the Eastern District of North Carolina, at Raleigh. Terrence W. Boyle, District

Judge. (CA-95-907-5-CT-BO)

Submitted: April 17, 1997 Decided: April 30, 1997

Before NIEMEYER and WILLIAMS, Circuit Judges, and BUTZNER, Senior

Circuit Judge.

Affirmed by unpublished per curiam opinion.

Wilbur Davis, Appellant Pro Se. John A. Maxfield, Michael R.

Ferrell, COUNTY ATTORNEY'S OFFICE OF THE COUNTY OF WAKE, Raleigh,

North Carolina, for Appellees.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
2
3

PER CURIAM:

Appellant appeals the district court's order denying relief on

his 42 U.S.C. § 1983 (1994) complaint. We have reviewed the record

and the district court's opinion and find no reversible error.

Accordingly, we affirm on the reasoning of the district court.

Davis v. Baxley, No. CA-95-907-5-CT-BO (E.D.N.C. Dec. 11, 1996). We

dispense with oral argument because the facts and legal contentions

are adequately presented in the materials before the court and

argument would not aid the decisional process.

AFFIRMED
[Federal Register Volume 89, Number 30 (Tuesday, February 13, 2024)]
[Notices]
[Page 10080]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-02883]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to 5 U.S.C. 1009(d), notice is hereby given of the 
following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Director, Office of 
Strategic Business Initiatives, Office of the Chief Operating Officer, 
CDC, pursuant to Public Law 92-463. The grant applications and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.
    Name of Committee: Disease, Disability, and Injury Prevention and 
Control Special Emphasis Panel (SEP)--SIP24-009, Arthritis Management 
and Wellbeing Network (AMWN).
    Date: May 15, 2024.
    Time: 10 a.m.-6 p.m., EDT.
    Place: Teleconference/Web Conference.
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Natalie Brown, M.P.H., Scientific 
Review Officer, National Center for Chronic Disease Prevention and 
Health Promotion, Centers for Disease Control and Prevention, 4770 
Buford Highway, Mailstop S106-3, Atlanta, Georgia 30341-3717. 
Telephone: (404) 639-4601; Email: <a href="/cdn-cgi/l/email-protection#8fc1cdfde0f8e1bccfecebeca1e8e0f9"><span class="__cf_email__" data-cfemail="f9b7bb8b968e97cab99a9d9ad79e968f">[email protected]</span></a>.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-02883 Filed 2-12-24; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
##### 



EXHIBIT 32 CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350 Michael V. Shustek, as Chief Executive Officer of Vestin Mortgage, Inc., the sole Manager of Vestin
Fund I, LLC (the Registrant), and John Alderfer, as Chief Financial Officer of Vestin Mortgage,
Inc., hereby certify, pursuant to 18 U.S.C. §1350, that  (1)
    the Registrants Report on Form 10-Q for the period ended March 31, 2005, as
filed with the Securities and Exchange Commission on the date hereof (the Report),
fully complies with the applicable requirements of Section 13(a) or Section 15(d) of
the Securities Exchange Act of 1934; and(2)
    the information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Registrant. Dated: May 10, 2005
    
    /s/ Michael V. ShustekMichael V. Shustek*Chief Executive Officerof Vestin Mortgage, Inc.,Manager of the RegistrantDated: May 10, 2005
    
    /s/ John AlderferJohn Alderfer*Chief Financial Officerof Vestin Mortgage, Inc.,Manager of the Registrant
   * Michael V. Shustek and John Alderfer function, respectively, as the equivalent of the Chief
Executive Officer and Chief Financial Officer of the Registrant for purposes of 18 U.S.C. Section
1350. 30
Exhibit 4.25


 


(English Translation)


 


Letter Agreement
between Mr. Wang Jianzhou, executive director of Unicom,
 and Unicom with respect to the
Extension of the Service Agreement
 between Mr. Wang and Unicom


 


August 29, 2003


 

















 


To: Mr. Wang Jianzhou


 


Re: Extension of the “Service Agreement for
Executive Directors” (“Service Agreement”)


 


The three-year “Service
Agreement” between you and our company signed on May 26, 2000 provided the
service conditions during your employment as our executive director starting
from April 20, 2000. The “Service Agreement” expired on April 19, 2003, and our
company now wishes to extend such “Service Agreement”.


 


The provisions of this
Extension Notice are effective from April 20, 2004.


 


If you agree to accept the
relevant provisions, for the purpose of confirmation, please sign the
counterpart of this Notice hereunder and send it back to our Hong Kong office.


 


Regards,


 


 


China Unicom Limited


 


	
  /s/ Ye
  Fengping

  	
   

  
	
  Executive
  Director

  
	
  August 29,
  2003

  



 


 


Confirmed and Signed by Director:


 


	
  /s/ Wang
  Jianzhou

  	
   

  
	
  Wang
  Jianzhou

  
	
  August 29,
  2003
POWER OF ATTORNEY


      We the undersigned, officers and directors of Parlex Corporation, 
hereby severally constitute Herbert W. Pollack and Steven M. Millstein, and 
each of them singly, our true and lawful attorneys, with full power 
indicated below, to sign for us the Report on Form 10-K of Parlex 
Corporation for the fiscal year ended June 30, 1996 and any required 
amendments thereto, hereby ratifying and confirming our signatures as they 
may be signed by our said attorneys to said Report and any and all such 
amendments.

      Witness our hands on the dates set forth below:


Dated:


*/S/ Sheldon A. Buckler                Director
-------------------------------
Sheldon A. Buckler



*/S/ Richard W. Hale                   Director
-------------------------------
Richard W. Hale



*/S/ M. Joel Kosheff                   Director
-------------------------------
M. Joel Kosheff



*/S/ Peter J. Murphy                   Director
-------------------------------
Peter J. Murphy



*/S/ Lester Pollack                    Director
-------------------------------
Lester Pollack



*/S/ Benjamin Rabinovici               Director
-------------------------------
Benjamin Rabinovici
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Office of Personnel Management

          - 5 CFR Part 532
          - [Docket ID: OPM-2023-0028]
          - RIN 3206-AO64

# AGENCY:

Office of Personnel Management.

# ACTION:

Final rule; correction.

# SUMMARY:

                        This document corrects the amendatory instructions in a final rule that was published in the                         **Federal Register**                         on January 24, 2024, regarding updates to the North American Industry Classification System Based Federal Wage System Wage Surveys.                    

# DATES:

Effective February 23, 2024.

# FOR FURTHER INFORMATION CONTACT:

                        Ana Paunoiu, by telephone at (202) 606-2858, or by email at                         *paypolicy@opm.gov.*

# SUPPLEMENTARY INFORMATION:

                    In the                     **Federal Register**                     of January 24, 2024, in FR Doc. 2024-01086, beginning on page 4539, the following corrections are made:                

§ 532.287

1. On page 4541, in the first column, in amendatory instruction 7 for § 532.287: 

a. In instruction a., the instruction “Removing the column heading “2017 NAICS codes” and adding in its place “2022 NAICS codes” ” is corrected to read “Removing the “2012 NAICS Codes” and adding in its place “2022 NAICS codes” ”. 

b. In instruction b., the instruction “Removing the column heading “2017 NAICS industry titles” and adding in its place “2022 NAICS industry titles” ” is corrected to read “Removing the column heading “2012 NAICS Industry titles” and adding in its place “2022 NAICS industry titles” ”. 

Dated: February 1, 2024.

Kayyonne Marston,

Federal Register Liaison.

[FR Doc. 2024-02319 Filed 2-5-24; 8:45 am]

BILLING CODE 6325-39-P
---

Exhibit 32.1



CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS
ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF
2002



In connection with the Quarterly Report of Communicate.com Inc.
(the Company) on Form 10-QSB for the period ending September 30, 2007 as filed
with the Securities and Exchange Commission on the date hereof (the Report),
I, C. Geoffrey Hampson, Chief Executive Officer of the Company, do hereby
certify, pursuant to § 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. § 1350),
that:

| | (1) | The Report fully complies with the requirements of
      section 13(a) or 15(d) of the Securities Exchange Act of 1934;
  and                                  
| | --- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------
| |     |                                                                                                                                                                
| | (2) | The information contained in the Report fairly presents,
      in all material respects, the financial condition and result of operations
      of the Company.



/s/ C Geoffrey HampsonC Geoffrey Hampson Chief
Executive Officer November 19, 2007

---
EXHIBIT 32.1

      CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT
                TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of OnScreen Technologies, Inc. (the
"Company"), on Form 10-QSB of the quarter ended March 31, 2006, I hereby certify
solely for the purpose of complying with 18 U.S.C. Section 1350, as adopted to
Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

(1) The quarterly report fully complies with the requirements of Section 13 (a)
or 15 (d) of the Securities Exchange Act of 1934; and

(2) The information contained in the quarterly report fairly presents, in all
material respects, the financial condition and results of operations of the
Company

OnScreen Technologies, Inc.


By:  /s/  Charles R. Baker                Dated this 15th day of May 2006
    -------------------------------------
          Charles R. Baker
    Chief Executive Officer/Director


                                       24
<TABLE> <S> <C>

<ARTICLE> 9
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                           3,070
<INT-BEARING-DEPOSITS>                               0
<FED-FUNDS-SOLD>                                     0
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                     25,720
<INVESTMENTS-CARRYING>                               0
<INVESTMENTS-MARKET>                                 0
<LOANS>                                         51,183
<ALLOWANCE>                                       (908)
<TOTAL-ASSETS>                                  84,051
<DEPOSITS>                                      73,120
<SHORT-TERM>                                         0
<LIABILITIES-OTHER>                              2,108
<LONG-TERM>                                          0
<COMMON>                                         2,805
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                      4,356
<OTHER-SE>                                       1,662
<TOTAL-LIABILITIES-AND-EQUITY>                  84,051
<INTEREST-LOAN>                                  4,732
<INTEREST-INVEST>                                1,567
<INTEREST-OTHER>                                   155
<INTEREST-TOTAL>                                 6,454
<INTEREST-DEPOSIT>                               2,427
<INTEREST-EXPENSE>                               2,428
<INTEREST-INCOME-NET>                            4,026
<LOAN-LOSSES>                                      511
<SECURITIES-GAINS>                                   0
<EXPENSE-OTHER>                                  3,300
<INCOME-PRETAX>                                  1,326
<INCOME-PRE-EXTRAORDINARY>                           0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       935
<EPS-PRIMARY>                                     0.21
<EPS-DILUTED>                                        0
<YIELD-ACTUAL>                                       0
<LOANS-NON>                                         87
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                   538
<CHARGE-OFFS>                                     (287)
<RECOVERIES>                                       146 
<ALLOWANCE-CLOSE>                                  908
<ALLOWANCE-DOMESTIC>                                 0
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                            432
        


</TABLE>
**EXHIBIT      31.1**

**CERTIFICATIONS**

|   | 1. | I                have reviewed this Amendment No. 1 to Annual Report on Form 10-K                of                Merisel, Inc.; |
|--------|----|-----------------------------------------------------------------------------------------------------------------------------------|

|   | 2. | Based                on my knowledge, this report does not contain any untrue statement                of a                material fact or omit to state a material fact necessary to make                the                statements made, in light of the circumstances under which such statements                were made, not misleading with respect to the period covered by this                report; |
|--------|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 3. | [Intentionally                omitted]; |
|--------|----|-----------------------------------------|

|   | 4. | [Intentionally                omitted]; |
|--------|----|-----------------------------------------|

|   | 5. | [Intentionally                omitted]. |
|--------|----|-----------------------------------------|

|                                          |                                                                                  |                              |
|-----------------------------------------------|---------------------------------------------------------------------------------------|-----------------------------------|
|                                          |                                                                                  |
|                                     |                                                                             |                         |
| Date:                 September 29, 2006 |                                                                                  | /s/                Donald R. Uzzi |
|                                          | Donald                R. Uzzi                                                         |
|                                          | Title:                Chairman, Chief Executive Officer, and                President |
[Federal Register Volume 89, Number 30 (Tuesday, February 13, 2024)]
[Notices]
[Pages 10082-10083]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-02882]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to 5 U.S.C. 1009(d), notice is hereby given of the 
following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Director, Office of 
Strategic Business

[[Page 10083]]

Initiatives, Office of the Chief Operating Officer, CDC, pursuant to 
Public Law 92-463. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.
    Name of Committee: Disease, Disability, and Injury Prevention and 
Control Special Emphasis Panel (SEP)--SIP24-008, Managing Epilepsy Well 
Network (MEW).
    Date: May 9, 2024.
    Time: 10 a.m.-6 p.m., EDT.
    Place: Teleconference/Web Conference.
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Catherine Barrett, Ph.D., 
Scientific Review Officer, National Center for Chronic Disease 
Prevention and Health Promotion, Centers for Disease Control and 
Prevention, 4770 Buford Highway, Mailstop S106-3, Atlanta, Georgia 
30341-3717. Telephone: (404) 718-7664; Email: <a href="/cdn-cgi/l/email-protection#347776554646514040745750571a535b42"><span class="__cf_email__" data-cfemail="c78485a6b5b5a2b3b387a4a3a4e9a0a8b1">[email protected]</span></a>.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-02882 Filed 2-12-24; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>